ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosisS. Cotte, Andrew Chan, Nicolas von Ahsen et al.|Brain|2009Cited by 74
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Bruno Stankoff, Franziska Di Pauli et al.|Multiple Sclerosis Journal|2022Cited by 46